News & Insights

Praedicat in the news.

Read what we think and what others think, all meant to make you think.

Praedicat Posts on Cometa

Praedicat announces new partnership with Apollo
Praedicat announces new partnership with Apollo 700 350 Bob Reville

Praedicat + Apollo!  Apollo understands that underwriters have always faced a litany of challenges when addressing emerging risk. They also understand that in today’s environment of relentless innovation, the challenge…

read more

Praedicat’s Latest Product Update- ChemMeta Notifications
Praedicat’s Latest Product Update- ChemMeta Notifications 750 350 Meghan Dengler

June 2nd 2020: Introducing ChemMeta notifications! . The Latest Science In Your Inbox . Praedicat is pleased to announce the newest enhancement in ChemMeta. This latest update features the highly anticipated…

read more

Praedicat’s Latest CoMeta Update- Sugar, Diesel, & Addictive Software Design
Praedicat’s Latest CoMeta Update- Sugar, Diesel, & Addictive Software Design 1910 809 Meghan Dengler

April 9th 2020: Praedicat’s Latest CoMeta Update – Sugar, Diesel, and Addictive Software Design On the heels of our CoMeta “Company Underwriting” release, Praedicat is pleased to announce a new…

read more

Praedicat’s Latest Product Release – Company Underwriting in CoMeta
Praedicat’s Latest Product Release – Company Underwriting in CoMeta 1280 450 Meghan Dengler

April 1st 2020: Praedicat’s Latest Product Release – Company Underwriting in CoMeta Here at Praedicat, we remain more committed than ever in our efforts to bring our clients great service…

read more

NTP prepares to classify antimony trioxide as a carcinogen
NTP prepares to classify antimony trioxide as a carcinogen 150 150 Adam Grossman

The U.S. National Toxicology Program (NTP) recently completed its draft evaluation of antimony trioxide as a human carcinogen. While the draft is still open for peer review and comment, the…

read more

Separating the Rumors from the Science: Rivaroxaban
Separating the Rumors from the Science: Rivaroxaban 150 150 Sheryll Mangahas

CoMeta™ Life Science adds pharmaceutical Litagion® agent profiles to CoMeta focusing on evaluating the liability that could arise from a manufacturer’s failure to warn physicians regarding the risk of specific…

read more
Start Typing